The ESETT Trial: 2nd Line Medications in Status Epilepticus
Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal. While most seizure activity responds to appropriately dosed benzodiazipines, some will...
Marco Torres |